White House Now Approves FDA’s New Rules that May Delay Virus Vaccine

The U.S. Food and Drug Administration (FDA), overcoming the White House’s initial opposition, released new safety guidelines Tuesday for drugmakers working for months on developing a Chinese virus vaccine. The move could prevent or delay introducing a potentially safe and effective final product before Election Day and beyond.

We are ad-free!

support

Share this: